April 17, 2023
A Closing Thought
32
4
Through grassroots patient education, local pharmacies serve as a pivotal doorway to improving access to trials.
April 17, 2023
Feature Articles
32
4
Determining if an EAC is at risk and key actions to mitigate trial impact.
April 17, 2023
Feature Articles
32
4
Strategies for intervention—or, ideally, averting potential pitfalls from the onset.
April 14, 2023
Feature Articles
32
4
Statistical methods used via this technique in centralized monitoring.
April 14, 2023
Data Collection
32
4
CDISC standards applicable to ePRO and other types of eCOA are still behind in the current regulatory landscape.
April 14, 2023
Q&A
32
4
PV is on the road to becoming a leader, not a follower, in leveraging drug lifecycle information for clinical trials and to inform clinical care.
April 13, 2023
From the Editor
32
4
Identifying key differences between PV and drug safety.
March 22, 2023
View from Brussels
32
4
The hopes for increased transparency in clinical research beginning to take shape as sponsors get up to speed with new reporting obligations.
March 03, 2023
View from Washington
32
4
The key issues for industry and FDA as the Orphan Drug Act hits its 40th anniversary.